Barclays PLC Boosts Stock Holdings in Adverum Biotechnologies, Inc. (NASDAQ:ADVM)
Barclays PLC boosted its position in Adverum Biotechnologies, Inc. (NASDAQ:ADVM – Free Report) by 11.3% during the 4th quarter, Holdings Channel.com reports. The firm owned 39,887 shares of the biotechnology company’s stock after purchasing an additional 4,055 shares during the period. Barclays PLC’s holdings in Adverum Biotechnologies were worth $186,000 as of its most recent […]
